Inflammatory disorders and allergies and risk of MM in white and black US male veterans
| . | Whites . | Blacks . | Combined . | ||||||
|---|---|---|---|---|---|---|---|---|---|
| N . | RR* . | 95% CI . | N . | RR* . | 95% CI . | N . | RR* . | 95% CI . | |
| Total inflammatory disorders | 807 | 1.17 | 1.07-1.27 | 362 | 1.22 | 1.07-1.38 | 1169 | 1.18 | 1.10-1.27 |
| Atrophic gastritis | 10 | 1.16 | 0.55-2.43 | 5 | 1.54 | 0.64-3.72 | 15 | 1.29 | 0.73-2.28 |
| Chronic bronchitis | 190 | 0.95 | 0.81-1.12 | 67 | 1.06 | 0.82-1.38 | 257 | 0.98 | 0.86-1.12 |
| Dacryadenitis | 6 | 1.21 | 0.54-2.70 | 4 | — | — | 10 | 1.44 | 0.77-2.68 |
| Dermatitis | 25 | 0.69 | 0.46-1.05 | 6 | 0.91 | 0.41-2.02 | 31 | 0.73 | 0.51-1.06 |
| Glomerulonephritis | 45 | 1.90 | 1.33-2.73 | 35 | 1.02 | 0.68-1.51 | 80 | 1.37 | 1.05-1.79 |
| Nephrotic syndrome | 29 | 2.53 | 1.43-4.46 | 15 | 1.79 | 0.93-3.44 | 44 | 2.15 | 1.40-3.30 |
| Osteoarthritis | 510 | 1.23 | 1.11-1.36 | 232 | 1.36 | 1.17-1.57 | 742 | 1.27 | 1.17-1.38 |
| Pericarditis, nonrheumatic | 16 | 1.32 | 0.76-2.27 | 8 | 1.18 | 0.56-2.47 | 24 | 1.26 | 0.81-1.96 |
| Prostatitis | 17 | 1.01 | 0.60-1.67 | 4 | — | — | 21 | 0.87 | 0.55-1.40 |
| Valvular disease, nonrheumatic | 80 | 1.09 | 0.85-1.39 | 32 | 0.83 | 0.56-1.24 | 112 | 1.00 | 0.81-1.23 |
| Total allergies | 169 | 1.04 | 0.89-1.23 | 88 | 1.20 | 0.96-1.51 | 257 | 1.09 | 0.96-1.25 |
| Allergic rhinitis | 16 | 1.56 | 0.95-2.55 | 4 | — | — | 20 | 1.45 | 0.93-2.25 |
| Asthma | 51 | 0.87 | 0.65-1.17 | 40 | 1.18 | 0.84-1.64 | 91 | 0.98 | 0.79-1.22 |
| Eczema and dermatitis | 75 | 1.08 | 0.85-1.37 | 34 | 1.20 | 0.84-1.70 | 109 | 1.11 | 0.91-1.35 |
| Erythema | 24 | 1.05 | 0.69-1.60 | 8 | 0.98 | 0.47-1.96 | 32 | 1.03 | 0.72-1.48 |
| Urticaria | 8 | 0.79 | 0.35-1.76 | 6 | 1.99 | 0.89-4.44 | 14 | 1.13 | 0.64-1.99 |
| . | Whites . | Blacks . | Combined . | ||||||
|---|---|---|---|---|---|---|---|---|---|
| N . | RR* . | 95% CI . | N . | RR* . | 95% CI . | N . | RR* . | 95% CI . | |
| Total inflammatory disorders | 807 | 1.17 | 1.07-1.27 | 362 | 1.22 | 1.07-1.38 | 1169 | 1.18 | 1.10-1.27 |
| Atrophic gastritis | 10 | 1.16 | 0.55-2.43 | 5 | 1.54 | 0.64-3.72 | 15 | 1.29 | 0.73-2.28 |
| Chronic bronchitis | 190 | 0.95 | 0.81-1.12 | 67 | 1.06 | 0.82-1.38 | 257 | 0.98 | 0.86-1.12 |
| Dacryadenitis | 6 | 1.21 | 0.54-2.70 | 4 | — | — | 10 | 1.44 | 0.77-2.68 |
| Dermatitis | 25 | 0.69 | 0.46-1.05 | 6 | 0.91 | 0.41-2.02 | 31 | 0.73 | 0.51-1.06 |
| Glomerulonephritis | 45 | 1.90 | 1.33-2.73 | 35 | 1.02 | 0.68-1.51 | 80 | 1.37 | 1.05-1.79 |
| Nephrotic syndrome | 29 | 2.53 | 1.43-4.46 | 15 | 1.79 | 0.93-3.44 | 44 | 2.15 | 1.40-3.30 |
| Osteoarthritis | 510 | 1.23 | 1.11-1.36 | 232 | 1.36 | 1.17-1.57 | 742 | 1.27 | 1.17-1.38 |
| Pericarditis, nonrheumatic | 16 | 1.32 | 0.76-2.27 | 8 | 1.18 | 0.56-2.47 | 24 | 1.26 | 0.81-1.96 |
| Prostatitis | 17 | 1.01 | 0.60-1.67 | 4 | — | — | 21 | 0.87 | 0.55-1.40 |
| Valvular disease, nonrheumatic | 80 | 1.09 | 0.85-1.39 | 32 | 0.83 | 0.56-1.24 | 112 | 1.00 | 0.81-1.23 |
| Total allergies | 169 | 1.04 | 0.89-1.23 | 88 | 1.20 | 0.96-1.51 | 257 | 1.09 | 0.96-1.25 |
| Allergic rhinitis | 16 | 1.56 | 0.95-2.55 | 4 | — | — | 20 | 1.45 | 0.93-2.25 |
| Asthma | 51 | 0.87 | 0.65-1.17 | 40 | 1.18 | 0.84-1.64 | 91 | 0.98 | 0.79-1.22 |
| Eczema and dermatitis | 75 | 1.08 | 0.85-1.37 | 34 | 1.20 | 0.84-1.70 | 109 | 1.11 | 0.91-1.35 |
| Erythema | 24 | 1.05 | 0.69-1.60 | 8 | 0.98 | 0.47-1.96 | 32 | 1.03 | 0.72-1.48 |
| Urticaria | 8 | 0.79 | 0.35-1.76 | 6 | 1.99 | 0.89-4.44 | 14 | 1.13 | 0.64-1.99 |
— indicates RR and CI not calculated due to small numbers.
RR adjusted for visits, attained age, calendar time, and latency (combined also adjusted for race).